Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms SNIPER(ABL)-3 |
Target |
Action degraders |
Mechanism Bcr-Abl degraders(Bcr-Abl tyrosine kinase degraders) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC51H65N9O5 |
InChIKeyXGWLZLZJIVJHNU-IZBWAPRPSA-N |
CAS Registry- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chronic Myelogenous Leukemia | Preclinical | Japan | 15 Oct 2016 |